Attached files

file filename
EX-31.1 - EXHIBIT 31.1 CEO CERTIFICATION - MICRON SOLUTIONS INC /DE/ex31110qjune2015ceo.htm
EX-32.1 - EXHIBIT 32.1 CEO CERTIFICATION - MICRON SOLUTIONS INC /DE/ex32110qjune2015ceo.htm
EX-31.2 - EXHIBIT 31.2 CFO CERTIFICATION - MICRON SOLUTIONS INC /DE/ex31210qjune2015cfo.htm
EX-3.2 - EXHIBIT 3.2 CERTIFICATE OF AMENDMENT OF CERTIFICATE OF INCORPORATION - MICRON SOLUTIONS INC /DE/ex32certificateofamendment.htm
10-Q - 10-Q 06 30 2015 - MICRON SOLUTIONS INC /DE/hrt10-q06302015.htm
EX-10.61 - EXHIBIT 10.61 4TH AMENDMENT TO LOAN AND SECURITY AGREEMENT - MICRON SOLUTIONS INC /DE/ex10614thamendmenttoloanan.htm


Exhibit 32.2



CERTIFICATION PURSUANT TO
18 U.S.C. §1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Quarterly Report on Form 10-Q of Arrhythmia Research Technology, Inc. (the “Company”) for the quarter ended June 30, 2015, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned principal financial and accounting officer certifies, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
 

(1)
 The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 
Date: August 13, 2015
 
/s/ Derek T. Welch
Derek T. Welch
Chief Financial Officer
(principal financial and accounting officer)


X-6